Francesca Crovetto
Overview
Explore the profile of Francesca Crovetto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
81
Citations
783
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ramos A, Youssef L, Molina P, Martinez-Sanchez J, Moreno-Castano A, Blasco M, et al.
Acta Obstet Gynecol Scand
. 2025 Feb;
PMID: 40007223
Introduction: Our objective was to evaluate the endothelial function profile and complement system in fetuses from preeclamptic pregnancies using ex vivo and in vitro approaches. Material And Methods: A total...
2.
Comte V, Alenya M, Urru A, Recober J, Nakaki A, Crovetto F, et al.
Heliyon
. 2025 Jan;
11(1):e40148.
PMID: 39816514
Deformable image registration is a cornerstone of many medical image analysis applications, particularly in the context of fetal brain magnetic resonance imaging (MRI), where precise registration is essential for studying...
3.
Ramos A, Youssef L, Molina P, Torramade-Moix S, Martinez-Sanchez J, Moreno-Castano A, et al.
Front Immunol
. 2024 Dec;
15:1488127.
PMID: 39735539
Background: Preeclampsia (PE) is a pregnancy complication characterized by hypertension, proteinuria, endothelial dysfunction, and complement dysregulation. Placenta-derived extracellular vesicles (EVs), necessary in maternal-fetal communication, might contribute to PE pathogenesis. Moreover,...
4.
Sanchez-Martinez S, Marti-Castellote P, Hoodbhoy Z, Bernardino G, Prats-Valero J, Aguado A, et al.
BMJ Glob Health
. 2024 Dec;
9(12).
PMID: 39638610
Introduction: Adverse perinatal outcomes (APO) pose a significant global challenge, particularly in low- and middle-income countries (LMICs). This study aims to analyse two cohorts of high-risk pregnant women for APO...
5.
Allotey J, Archer L, Snell K, Coomar D, Masse J, Sletner L, et al.
BMJ Med
. 2024 Aug;
3(1):e000784.
PMID: 39184566
Objective: To predict birth weight at various potential gestational ages of delivery based on data routinely available at the first antenatal visit. Design: Individual participant data meta-analysis. Data Sources: Individual...
6.
Nakaki A, Gomez Y, Darecka K, Borras R, Vellve K, Paules C, et al.
Fetal Diagn Ther
. 2024 Jul;
52(1):46-58.
PMID: 39079502
Introduction: We investigated whether structured maternal lifestyle interventions based on Mediterranean diet or stress reduction influence fetal-infant neurodevelopment detected by detailed fetal neurosonography and Ages and Stages Questionnaires 3rd edition...
7.
Nakaki A, Denaro E, Crimella M, Castellani R, Vellve K, Izquierdo N, et al.
Acta Obstet Gynecol Scand
. 2024 Jul;
103(10):2042-2052.
PMID: 39037192
Introduction: The IMPACT BCN trial-a parallel-group randomized clinical trial where 1221 pregnant women at high risk for small-for-gestational age (SGA) newborns were randomly allocated at 19- to 23-week gestation into...
8.
Nakaki A, Gomez Y, Castro-Barquero S, Conti A, Vellve K, Casas I, et al.
Nutrients
. 2024 Jun;
16(11).
PMID: 38892540
Introduction: A Mediterranean diet has positive effects on the brain in mid-older adults; however, there is scarce information on pregnant individuals. We aimed to evaluate the effect of a structured...
9.
Castro-Barquero S, Crovetto F, Estruch R, Ruiz-Leon A, Larroya M, Sacanella E, et al.
Am J Clin Nutr
. 2024 Jun;
120(2):449-458.
PMID: 38830408
Background: Non-time-consuming and easy-to-administer dietary assessment tools specific for pregnancy are needed. Objectives: The aim of this validation study nested in the IMPACT BCN (Improving Mothers for a better PrenAtal...
10.
Benitez L, Castro-Barquero S, Crispi F, Youssef L, Crovetto F, Fischer U, et al.
Fetal Diagn Ther
. 2024 May;
51(4):395-410.
PMID: 38710162
Background: Acute leukemia is the most common pediatric cancer, with an incidence peak at 2-5 years of age. Despite the medical advances improving survival rates, children suffer from significant side...